Amgen Inc Stock Today

AMGN Stock  USD 265.51  1.77  0.66%   


0 of 100

Very Weak

Odds Of Distress

Less than 6

Amgen is selling at 265.51 as of the 16th of April 2024; that is -0.66 percent decrease since the beginning of the trading day. The stock's open price was 267.28. Amgen has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Amgen Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of March 2024 and ending today, the 16th of April 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
17th of June 1983
Health Care
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. The company has 535.92 M outstanding shares of which 10.47 M shares are presently shorted by private and institutional investors with about 3.39 trading days to cover. More on Amgen Inc

Moving together with Amgen Stock

  0.79VRTX Vertex Pharmaceuticals Financial Report 6th of May 2024 PairCorr

Moving against Amgen Stock

  0.82RZLT Rezolute TrendingPairCorr
  0.81NVO Novo Nordisk AS Financial Report 2nd of May 2024 PairCorr
  0.75ERAS Erasca Inc Financial Report 20th of May 2024 PairCorr
  0.71CELC Celcuity LLC Financial Report 20th of May 2024 PairCorr
  0.69CCCC C4 TherapeuticsInc Financial Report 2nd of May 2024 PairCorr
  0.68INDP Indaptus Therapeutics Financial Report 9th of May 2024 PairCorr
  0.61BMY Bristol Myers Squibb Financial Report 25th of April 2024 PairCorr

Amgen Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Amgen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amgen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Amgen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amgen's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
ChairmanRobert Bradway
Thematic Ideas
Showing 3 out of 7 themes
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Dow Jones Industrial, NASDAQ 100 Pre, NASDAQ Biotechnology, SP 500 Index, SP 100 Index, SP 100, ARCA Biotechnology, Nasdaq 100, Dow Jones Biotechnology, NASDAQ Health Care, NASDAQ Composite, ARCA Institutional, BETTERINVESTING 100 INDEX, BTRINVSTNG 100 INDEX, NASDAQ Composite Total, Drugs, Health Management, Macroaxis Index, Cash Cows, Baby Boomer Prospects, Giant Impact, Robots And Drones, Health Care, Biotechnology, Drug Manufacturers—General, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal TestingCatholic
Average Analyst Recommendation
Analysts covering Amgen report their recommendations after researching Amgen's financial statements, talking to executives and customers, or listening in on Amgen's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Amgen Inc. The Amgen consensus assessment is calculated by taking the average forecast from all of the analysts covering Amgen.
Financial Strength
Based on the analysis of Amgen's profitability, liquidity, and operating efficiency, Amgen Inc may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Amgen Inc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.120.0691
Way Up
Slightly volatile
Asset Turnover0.510.2902
Way Up
Slightly volatile
Gross Profit Margin0.650.7002
Significantly Down
Slightly volatile
Total Current Liabilities19.3 B18.4 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total76.2 B72.5 B
Sufficiently Up
Slightly volatile
Total Assets102 B97.2 B
Sufficiently Up
Slightly volatile
Total Current Assets15.2 B30.3 B
Way Down
Very volatile
Amgen's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Amgen's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Amgen's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Amgen's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Amgen's financial leverage. It provides some insight into what part of Amgen's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Amgen's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Amgen deploys its capital and how much of that capital is borrowed.
Amgen cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 64.61 B in liabilities. Amgen Inc has a current ratio of 1.65, which is within standard range for the sector. Debt can assist Amgen until it has trouble settling it off, either with new capital or with free cash flow. So, Amgen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amgen Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amgen to invest in growth at high rates of return. When we think about Amgen's use of debt, we should always consider it together with cash and equity.


4.27 Billion
Amgen Inc (AMGN) is traded on NASDAQ Exchange in USA. It is located in One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 and employs 26,700 people. Amgen is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 142.29 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amgen's market, we take the total number of its shares issued and multiply it by Amgen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Amgen Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 535.92 M outstanding shares of which 10.47 M shares are presently shorted by private and institutional investors with about 3.39 trading days to cover. Amgen Inc currently holds about 11.48 B in cash with 8.47 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.51.
Check Amgen Probability Of Bankruptcy
Ownership Allocation
Amgen holds a total of 535.92 Million outstanding shares. The majority of Amgen Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amgen Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amgen. Please pay attention to any change in the institutional holdings of Amgen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Amgen Ownership Details

Amgen Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Amgen jumping above the current price in 90 days from now is about 91.63%. The Amgen Inc probability density function shows the probability of Amgen stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Amgen has a beta of 0.8314. This suggests as returns on the market go up, Amgen average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Amgen Inc will be expected to be much smaller as well. Additionally, amgen Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 265.51HorizonTargetOdds Above 265.51
8.28%90 days
Based on a normal probability distribution, the odds of Amgen to move above the current price in 90 days from now is about 91.63 (This Amgen Inc probability density function shows the probability of Amgen Stock to fall within a particular range of prices over 90 days) .

Amgen Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Amgen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amgen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amgen's value.
InstituionRecorded OnShares
Northern Trust Corp2023-12-31
6.4 M
Royal Bank Of Canada2023-12-31
5.8 M
Bank Of New York Mellon Corp2023-12-31
5.5 M
Norges Bank2023-12-31
5.4 M
Legal & General Group Plc2023-12-31
Fmr Inc2023-12-31
4.8 M
Bank Of America Corp2023-12-31
4.3 M
Aristotle Capital Management Llc2023-12-31
4.2 M
Jpmorgan Chase & Co2023-12-31
Vanguard Group Inc
49 M
Blackrock Inc2023-12-31
47.8 M
View Amgen Diagnostics

Amgen Historical Income Statement

Amgen Inc Income Statement is one of the three primary financial statements used for reporting Amgen's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Amgen Inc revenue and expense. Amgen Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Amgen's Cost Of Revenue is very stable compared to the past year. As of the 16th of April 2024, Total Operating Expenses is likely to grow to about 12.4 B, while Operating Income is likely to drop about 4.1 B. View More Fundamentals

Amgen Stock Against Markets

Picking the right benchmark for Amgen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Amgen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Amgen is critical whether you are bullish or bearish towards Amgen Inc at a given time. Please also check how Amgen's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amgen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamental Analysis Now


Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module

Amgen Corporate Directors

Amgen corporate directors refer to members of an Amgen board of directors. The board of directors generally takes responsibility for the Amgen's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Amgen's board members must vote for the resolution. The Amgen board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Frank HerringerIndependent DirectorProfile
Francois CarbonnelIndependent DirectorProfile
Rebecca HendersonIndependent DirectorProfile
Sanders WilliamsIndependent DirectorProfile

How to buy Amgen Stock?

Before investing in Amgen, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Amgen. To buy Amgen stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Amgen. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Amgen stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Amgen Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Amgen Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Amgen Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Amgen Stock please use our How to Invest in Amgen guide.

Already Invested in Amgen Inc?

The danger of trading Amgen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amgen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amgen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amgen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Dividend Share
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.